<!DOCTYPE html>
<html>

<head>

<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">
<title>Clinical Practice Guidelines - Mechanical Ventilation</title>


<style type="text/css">
body {
  font-family: Helvetica, arial, sans-serif;
  font-size: 14px;
  line-height: 1.6;
  padding-top: 10px;
  padding-bottom: 10px;
  background-color: white;
  padding: 30px; }

body > *:first-child {
  margin-top: 0 !important; }
body > *:last-child {
  margin-bottom: 0 !important; }

a {
  color: #4183C4; }
a.absent {
  color: #cc0000; }
a.anchor {
  display: block;
  padding-left: 30px;
  margin-left: -30px;
  cursor: pointer;
  position: absolute;
  top: 0;
  left: 0;
  bottom: 0; }

h1, h2, h3, h4, h5, h6 {
  margin: 20px 0 10px;
  padding: 0;
  font-weight: bold;
  -webkit-font-smoothing: antialiased;
  cursor: text;
  position: relative; }

h1:hover a.anchor, h2:hover a.anchor, h3:hover a.anchor, h4:hover a.anchor, h5:hover a.anchor, h6:hover a.anchor {
  background: url(data:image/png;base64,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) no-repeat 10px center;
  text-decoration: none; }

h1 tt, h1 code {
  font-size: inherit; }

h2 tt, h2 code {
  font-size: inherit; }

h3 tt, h3 code {
  font-size: inherit; }

h4 tt, h4 code {
  font-size: inherit; }

h5 tt, h5 code {
  font-size: inherit; }

h6 tt, h6 code {
  font-size: inherit; }

h1 {
  font-size: 28px;
  color: black; }

h2 {
  font-size: 24px;
  border-bottom: 1px solid #cccccc;
  color: black; }

h3 {
  font-size: 18px; }

h4 {
  font-size: 16px; }

h5 {
  font-size: 14px; }

h6 {
  color: #777777;
  font-size: 14px; }

p, blockquote, ul, ol, dl, li, table, pre {
  margin: 15px 0; }

hr {
  background: transparent url(data:image/png;base64,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) repeat-x 0 0;
  border: 0 none;
  color: #cccccc;
  height: 4px;
  padding: 0;
}

body > h2:first-child {
  margin-top: 0;
  padding-top: 0; }
body > h1:first-child {
  margin-top: 0;
  padding-top: 0; }
  body > h1:first-child + h2 {
    margin-top: 0;
    padding-top: 0; }
body > h3:first-child, body > h4:first-child, body > h5:first-child, body > h6:first-child {
  margin-top: 0;
  padding-top: 0; }

a:first-child h1, a:first-child h2, a:first-child h3, a:first-child h4, a:first-child h5, a:first-child h6 {
  margin-top: 0;
  padding-top: 0; }

h1 p, h2 p, h3 p, h4 p, h5 p, h6 p {
  margin-top: 0; }

li p.first {
  display: inline-block; }
li {
  margin: 0; }
ul, ol {
  padding-left: 30px; }

ul :first-child, ol :first-child {
    margin-top: 0;
}

dl {
  padding: 0; }
  dl dt {
    font-size: 14px;
    font-weight: bold;
    font-style: italic;
    padding: 0;
    margin: 15px 0 5px; }
    dl dt:first-child {
      padding: 0; }
    dl dt > :first-child {
      margin-top: 0; }
    dl dt > :last-child {
      margin-bottom: 0; }
  dl dd {
    margin: 0 0 15px;
    padding: 0 15px; }
    dl dd > :first-child {
      margin-top: 0; }
    dl dd > :last-child {
      margin-bottom: 0; }

blockquote {
  border-left: 4px solid #dddddd;
  padding: 0 15px;
  color: #777777; }
  blockquote > :first-child {
    margin-top: 0; }
  blockquote > :last-child {
    margin-bottom: 0; }

table {
  padding: 0;border-collapse: collapse; }
  table tr {
    border-top: 1px solid #cccccc;
    background-color: white;
    margin: 0;
    padding: 0; }
    table tr:nth-child(2n) {
      background-color: #f8f8f8; }
    table tr th {
      font-weight: bold;
      border: 1px solid #cccccc;
      margin: 0;
      padding: 6px 13px; }
    table tr td {
      border: 1px solid #cccccc;
      margin: 0;
      padding: 6px 13px; }
    table tr th :first-child, table tr td :first-child {
      margin-top: 0; }
    table tr th :last-child, table tr td :last-child {
      margin-bottom: 0; }

img {
  max-width: 100%; }

span.frame {
  display: block;
  overflow: hidden; }
  span.frame > span {
    border: 1px solid #dddddd;
    display: block;
    float: left;
    overflow: hidden;
    margin: 13px 0 0;
    padding: 7px;
    width: auto; }
  span.frame span img {
    display: block;
    float: left; }
  span.frame span span {
    clear: both;
    color: #333333;
    display: block;
    padding: 5px 0 0; }
span.align-center {
  display: block;
  overflow: hidden;
  clear: both; }
  span.align-center > span {
    display: block;
    overflow: hidden;
    margin: 13px auto 0;
    text-align: center; }
  span.align-center span img {
    margin: 0 auto;
    text-align: center; }
span.align-right {
  display: block;
  overflow: hidden;
  clear: both; }
  span.align-right > span {
    display: block;
    overflow: hidden;
    margin: 13px 0 0;
    text-align: right; }
  span.align-right span img {
    margin: 0;
    text-align: right; }
span.float-left {
  display: block;
  margin-right: 13px;
  overflow: hidden;
  float: left; }
  span.float-left span {
    margin: 13px 0 0; }
span.float-right {
  display: block;
  margin-left: 13px;
  overflow: hidden;
  float: right; }
  span.float-right > span {
    display: block;
    overflow: hidden;
    margin: 13px auto 0;
    text-align: right; }

code, tt {
  margin: 0 2px;
  padding: 0 5px;
  white-space: nowrap;
  border: 1px solid #eaeaea;
  background-color: #f8f8f8;
  border-radius: 3px; }

pre code {
  margin: 0;
  padding: 0;
  white-space: pre;
  border: none;
  background: transparent; }

.highlight pre {
  background-color: #f8f8f8;
  border: 1px solid #cccccc;
  font-size: 13px;
  line-height: 19px;
  overflow: auto;
  padding: 6px 10px;
  border-radius: 3px; }

pre {
  background-color: #f8f8f8;
  border: 1px solid #cccccc;
  font-size: 13px;
  line-height: 19px;
  overflow: auto;
  padding: 6px 10px;
  border-radius: 3px; }
  pre code, pre tt {
    background-color: transparent;
    border: none; }

sup {
    font-size: 0.83em;
    vertical-align: super;
    line-height: 0;
}

kbd {
  display: inline-block;
  padding: 3px 5px;
  font-size: 11px;
  line-height: 10px;
  color: #555;
  vertical-align: middle;
  background-color: #fcfcfc;
  border: solid 1px #ccc;
  border-bottom-color: #bbb;
  border-radius: 3px;
  box-shadow: inset 0 -1px 0 #bbb
}

* {
	-webkit-print-color-adjust: exact;
}
@media screen and (min-width: 914px) {
    body {
        width: 854px;
        margin:0 auto;
    }
}
@media print {
	table, pre {
		page-break-inside: avoid;
	}
	pre {
		word-wrap: break-word;
	}
}
</style>


</head>

<body>

<h2 id="toc_0">Ornge Clinical Practice Guideline: Mechanical Ventilation</h2>
    <ol>
        <li>
            <p>Mechanical ventilation is usually indicated in the following scenarios:</p>
            <ol type="a">
                <li>Hypoxemic respiratory failure</li>
                <li>Hypercapneic respiratory failure</li>
                <li>Mixed hypoxemic/hypercapneic respiratory failure</li>
                <li>Transport of patient intubated for other reasons; i.e. airway protection for primary neurological issues, excessive secretions, shock</li>
            </ol>
        </li>
        <li>
            <p>Mechanical ventilation may be harmful to patients, especially those with acute lung injury (ALI)/acute respira- tory distress syndrome (ARDS), through one or more of the following mechanisms:</p>
            <ol type="a">
                <li>Volutrauma (excessive tidal volumes- ideal target 6 mL/kg ideal body weight to avoid alveolar over distension)</li>
                <li>Barotrauma (excessive plateau airway pressures- ideal target &lt; 30 cm H20)</li>
                <li>Atelectrauma (recurrent opening and closing of alveoli- ideal target of maintaining an “open” lung using PEEP)</li>
                <li>Biotrauma (release of local and systemic inflammatory cytokines/mediators from lungs due to volutrauma, barotrauma and atelectrauma)</li>
            </ol>
        </li>
        <li>
            <p>Appropriate endotracheal tube placement must be confirmed prior to departing the sending facility:</p>
            <ol type="a">
                <li>If available, a chest x-ray (CXR) should be reviewed by the Ornge team at the sending facility to confirm appropriate endotracheal tube depth of insertion. Alternatively confirmation of appropriate ETT position can be obtained through discussion with the sending physician or review of a final report from a radiologist</li>
                <li>Should the clinical situation warrant in the judgment of the Ornge crew and the TMP on duty, clinical confirmation of ETT position without radiological confirmation may be sufficient when delays in transport to definitive care place the patient at greater risk than the potential risk of transporting without review of the CXR</li>
                <li>Continuous ETCO2 monitoring should be performed to assist in detection of inadvertent ETT dislodgement during transport</li>
                <li>ETT must be properly secured during packaging for transport. In cases of anticipated potential difficulty in reintubation after potential ETT dislodgement, ongoing neuromuscular blockade in addition to heavy sedation should be considered</li>
            </ol>
        </li>
        <li>ETT cuff inflation pressures should be checked and documented for all intubated patients to avoid excessive cuff pressures, which can lead to tracheal ischemia and injury</li>
        <li>
            <p>Clamping of the ETT prior to any intentional disconnection from the ventilator (i.e., when transferring the patient from a hospital ventilator at the sending facility to the transport ventilator) should be performed to avoid lung de-recruitment, ensuring analgosedation +/- paralysis is maximized to prevent
            negative consequences such as pulmonary edema caused by maximal inspiration attempts against a
            clamped ETT.
            <p><strong>NOTE:</strong></p>
                    </p>
        <p>Unintentional ETT disconnection can result in rapid de-recruitment of the lung and should be reconnected
            as quickly as possible. </p>
    </li>
    <li>An appropriate mode of ventilation should be selected based on the patient condition:
        <ul>
            <li>Patients with spontaneous respiratory effort not requiring high levels of mechanical ventilation
                support should be ventilated using pressure support ventilation, which has been shown to
                decrease sedation requirements and provide better patient comfort. PSV levels should not be set
                &lt; 8 cm H2O</li>
            <li>Patients requiring higher levels of mechanical ventilation support due to severe respiratory failure,
                patients without adequate drive to breathe and patients who require control of ETCO2 for
                non-respiratory reasons should be ventilated using a controlled mode of ventilation (AC with
                pressure control or volume control)</li>
            <li>Ornge crews should be prepared to switch from pressure support to a controlled mode of ventilation
                in the event of oversedation or other change in clinical condition</li>
        </ul>
    </li>
    <li>Goal-directed ventilation should be provided by the Ornge crew using medical directives or direct medical
        control through patch as follows:
        <ul>
            <li>Initial inspired oxygen concentration should be determined by matching sending hospital settings
                or starting at 100% oxygen and titrating down based on oxygen saturation readings</li>
            <li>Oxygen saturation should be maintained routinely with a target of 94-98% [Consider changing this to 90-96% based on LOCO2 and ICU-ROX studies at least for ARDS. unless an alternate target is indicated]
                <ul>
                    <li>Hyperoxia can be harmful in settings of acute neurological injury (stroke, post-cardiac arrest)
                        and myocardial infarction. SpO2 should be targeted between 94-98% [Align this target with stroke directives: - I believe guideliens NICE, BTS, AHA suggest starting O2 when SpO2 drops below 95%]</li>
                    <li>High FiO2 (&gt;0.8) may be associated with increased risk of lung injury due to worsening of
                        lung inflammation</li>
                    <li>High FiO2 (&gt;0.8) may cause washout of nitrogen and subsequent alveolar micro-atelectasis</li>
                    <li>Oxygen saturation levels of 100% may be associated with extremely high PaO2 levels and should
                        be avoided</li>
                    <li>FiO2 should be titrated down as much as possible to avoid hyperoxia</li>
                    <li>[90-96% seems to be appropriate for these patients. LOCO2 would suggest those whos target was                        88% were more prone to hypoxemia. Suggest deleting these two points. ]</li>
                </ul>
            </li>
            <li>Permissive hypoxemia should be avoided in pregnant patients and patients with carbon monoxide poisoning, and in
                such cases higher than usual FiO2 may be maintained</li>
            <li>Consider reducing cabin altitude in patients with refractory hypoxemia as tolerated by operational constraints</li>
            <li>Adequate PEEP should be applied to maintain an open lung strategy, thereby avoiding atelectasis
                and potential lung injury, and also allowing reduction in FiO2
                <ul>
                    <li>All intubated patients should receive PEEP of at least 5 cm H2O to compensate for loss of physiological
                            PEEP due to endotracheal intubation</li>
                        <li>In patients with ARDS and FiO2 > 0.6, they should receive PEEP higher than 5 cm H2O to support
                            improved lung recruitment and allow eventual weaning of the FiO2</li>
                        <li>Patients with ARDS; as FiO2 is increased, PEEP should also be increased to improve lung recruitment
                            using the ARDSnet table as a guide</li>
                        <li>DeltaP (Pplat minus PEEP) should be less than 15 cm H2O as higher values are associated with
                            adverse outcomes/mortality</li>
                    </ul>
                </li>
                <li>I:E ratios are typically set at 1:2-1:3 for patients with minimal lung pathology
                    <ul>
                        <li>Consider adjusting the I:E ratio by increasing inspiratory time as another strategy to increase
                            mean airway pressure and therefore oxygenation (typically 1:1.5 or in extreme situations 1:1)</li>
                        <li>Inverse ratio ventilation (I time > E time) presents significant challenges in terms of ventilation
                            and hemodynamics, and should only be done after careful discussion with the TMP</li>
                        <li>Patients with severe expiratory air flow limitation (i.e. asthma, COPD) may require much longer
                            E time</li>
                        <li>Patients with hypercapnea associated with severe obstructive airway disease may require nonintuitive
                            strategies to lower PaCO2 such as reducing the respiratory rate and decreasing the I time</li>
                    </ul>
                </li>
                <li>Patients with ARDS and high FiO2 requirements and/or difficulty achieving oxygenation targets
                    should prompt consideration of a recruitment maneuver
                    <ul>
                        <li>A 30 cm H2O pressure delivered for 30 seconds or alternatively a 40 cm H20 pressure delivered for
                            40 seconds can be considered as tolerated by hemodynamics and oxygenation</li>
                        <li>Recruitment maneuvers should be ideally performed at the sending facility prior to
                            departing, ensuring ETT clamping during switch between ventilators to avoid alveolar de-recruitment
                            (refer to recruitment maneuver in Medical Directive)</li>
                        <li>Analgosedation +/- paralysis should be optimized prior to performing recruit maneuvers or
                            ETT clamping.</li>
                    </ul>
                </li>
                <li>Target tidal volume should be determined using a 6-8 mL/kg target, with calculated ideal body
                    weight based on height and gender-based formula for all mechanically ventilated patients. Note, if
                    PIP or plateau pressures >30 cm H2O, then adjust Vt target to 4-6 ml/kg IBW</li>
                <li>ETCO2 target should be determined for all mechanically ventilated patients based on clinical condition
                    and acid-base status
                    <ul>
                        <li>Default ETCO2 target is 35-45 mm Hg</li>
                        <li>Patients with increased ICP but no signs of herniation should have a target of an ETC02 33-38</li>
                        <li>Patients requiring immediate temporary relief of life-threatening high intracranial pressure or
                            herniation should have a target of an ETCO2 30-35 mm Hg (short-term mild hyperventilation)</li>
                        <li>Patients who have pre-existing acid-base disturbances should have an adjusted ETCO2 target
                            to account for differences in baseline bicarbonate levels
                            <ul>
                                <li>When available, patients should have a documented pCO2 and bicarbonate level from recent
                                    ABG, VBG, or electrolytes in the call report</li>
                                <li>Extreme bicarbonate levels should prompt an adjusted ETCO2 target to avoid causing
                                    extreme arterial pH through excessive hyper/hypoventilation
                                    <ul>
                                        <li>HCO3 > 35 should warrant a higher ETCO2 target</li>
                                        <li>HCO3 < 15 should warrant a lower ETCO2 target</li>
                                    </ul>
                                </li>
                            </ul>
                    </li>
                </ul>
            </li>
            <li>Ornge crews should determine the appropriate amount of Pressure Support or Pressure Control
                to achieve the target Vt, or monitor airway pressures if using a volume controlled mode of ventilation
                <ul>
                    <li>Plateau pressures of > 30 cm H20 should be avoided whenever possible to reduce the risk of
                        barotrauma (ventilator-induced lung injury, pneumothorax, pneumomediastinum).</li>
                    <li>For patients with poor respiratory system compliance which prevents achieving target Vt
                        without exceeding plateau pressures of > 30 cm H2O, the TMP should order a strategy of
                        permissive hypercapnea with target pH > 7.2-7.25 and adjusted higher ETCO2 target
                        depending on baseline serum bicarbonate (i.e., ETCO2 50-60); achieved with tidal volumes
                        4-6 ml/kg IBW. NOTE: tidal volume should never be set < 4 ml/kg IBW, as a result, PIP/Plateau
                        > 30 cm H2O may be tolerated; e.g. severe air flow obstruction (asthma)</li>
                    <li>Judicious use of sedation and neuromuscular blockade should be considered to improve respiratory
                        system compliance for those difficult to safely ventilate</li>
                    <li>The TMP should discuss with the sending facility alternate strategies to improve respiratory system
                        compliance prior to transport (i.e. drainage of pleural effusion, decompression of abdominal
                        distension with nasogastric tube placement, diuresis)</li>
                    <li>Consider other reversible factors contributing to higher driving pressure requirements and provide appropriate treatment
                        <ul>
                            <li>Bronchodilators for higher airway resistance in patients with asthma/COPD</li>
                            <li>Main stem bronchus intubation</li>
                            <li>Kinked ETT or patient chewing on the ETT</li>
                            <li>Suctioning of the ETT in case of excessive secretions</li>
                            <li>Decompression of a new pneumothorax</li>
                            <li>Diuresis in the setting of pulmonary edema</li>
                        </ul>
                    </li>
                </ul>
            </li>
            <li>Patients requiring mechanical ventilation should be provided measures to ensure their comfort and encourage
                ventilator/patient synchrony
                <ul>
                    <li>All intubated patients should receive analgesia to control their pain with infusion and/or bolus narcotic
                        agents</li>
                    <li>Ventilator/patient asynchrony may originate in the ventilator sensitivity setting; i.e. auto-cycling
                        during a turbulent transport; adjust the sensitivity to trigger only on patient-initiated efforts</li>
                    <li>Adequate sedation should be achieved using agents such as propofol, ketamine, or midazolam as required based on the patient's vital signs and   presenting condition</li>
                    <li>Ventilator synchrony may be better achieved using a combination of analgesia and sedation agents rather than single agents alone</li>
                    <li>Consider ketamine as first-line therapy in patients with borderline hemodynamics</li>
                    <li>Non-medication measures to improve patient comfort should be used when possible (i.e., noise reduction devices) to minimize the need for comfort medications</li>
                    <li>Patients who are difficult to ventilate/oxygenate may require deep sedation and/or neuromuscular blockade to allow optimal flexibility in providing mechanical ventilation support</li>
                </ul>
              </li>
          </ol>


</body>

</html>
